Correction to “ Treponema pallidum Flagellin FlaB3 Activates Inflammation and Inhibits Autophagy in HMC3 Cells via the TLR4 Pathway”
ACS Infectious Diseases · 14.08.2026 · 12 (8) · 2892-2893
DOI: 10.1021/acsinfecdis.6c00571 ↗Kurz gefasst
Korrektur in der Zeitschrift ACS Infectious Diseases, online erschienen am 01.07.2026. Verfasst von Fangzhi Du und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Gefördert von: Chinese Academy of Medical Sciences, Yunnan Provincial Science and Technology Department, Special Research Fund for Central Universities, Peking Union Medical College.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
ORCID-Profile: Qianqiu Wang
Förderung
- Chinese Academy of Medical Sciences
- Yunnan Provincial Science and Technology Department
- Special Research Fund for Central Universities, Peking Union Medical College
- Jiangsu Provincial Medical Key Laboratory, Jiangsu Province Capability Improvement Project through Science, Technology and Education
Zitieren
APA
Du, F., Lu, Z., Wu, Q., Zhang, X., Zheng, X., Zhang, R., & Wang, Q. (2026). Correction to “ Treponema pallidum Flagellin FlaB3 Activates Inflammation and Inhibits Autophagy in HMC3 Cells via the TLR4 Pathway”. ACS Infectious Diseases, 12(8), 2892-2893. https://doi.org/10.1021/acsinfecdis.6c00571
Vancouver
Du F, Lu Z, Wu Q, Zhang X, Zheng X, Zhang R, et al. Correction to “ Treponema pallidum Flagellin FlaB3 Activates Inflammation and Inhibits Autophagy in HMC3 Cells via the TLR4 Pathway”. ACS Infectious Diseases. 2026;12(8):2892-2893. doi:10.1021/acsinfecdis.6c00571
BibTeX
@article{Du2026,
author = {Du, Fangzhi and Lu, Zhiyu and Wu, Qingyun and Zhang, Xu and Zheng, Xiaoli and Zhang, Ruili and Wang, Qianqiu},
title = {Correction to “ Treponema pallidum Flagellin FlaB3 Activates Inflammation and Inhibits Autophagy in HMC3 Cells via the TLR4 Pathway”},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {8},
pages = {2892--2893},
doi = {10.1021/acsinfecdis.6c00571}
}
EUVIMED